Lack of association between clinical and cognitive change in first-episode psychosis: the first 6 weeks of treatment.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Canadian journal of psychiatry. Revue canadienne de psychiatrie

• Publication date

  2008-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 19087482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pretreatment predictors of cognitive deficits in early psychosis

  2007cited by this paper
• Cognitive remediation therapy in schizophrenia: randomised controlled trial.

  2007cited by this paper
• Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.

  2007cited by this paper
• Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?

  2007cited by this paper
• Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

  2007cited by this paper
• Cognitive dimensions in first-episode schizophrenia spectrum disorders.

  2007cited by this paper
• Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index.

  2007cited by this paper
• Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.

  2006cited by this paper
• Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders

  2006cited by this paper
• The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements

  2006cited by this paper
• Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments.

  2006cited by this paper
• A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

  2006cited by this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• First-episode psychosis: psychopathology, quality of life, and functional outcome.

  2005cited by this paper
• A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

  2005cited by this paper
• Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.

  2005cited by this paper
• Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia.

  2005cited by this paper
• Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder.

  2004cited by this paper
• Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.

  2004cited by this paper
• Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.

  2004cited by this paper
• Correlates of cognitive deficits in first episode schizophrenia.

  2004cited by this paper
• Cognitive deficits as treatment targets in schizophrenia.

  2004cited by this paper
• Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.

  2004cited by this paper
• Neuropsychological correlates of symptom profiles in first episode schizophrenia.

  2004cited by this paper
• Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.

  2003cited by this paper
• Medicine. What are the right targets for psychopharmacology?

  2003cited by this paper
• Effects of risperidone on information processing and attention in first-episode schizophrenia.

  2002cited by this paper
• Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia.

  2002cited by this paper
• Practice effects on cognitive tasks: a major problem?

  2002cited by this paper
• DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS

  2002cited by this paper
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

  2001cited by this paper
• Neuropsychological change in schizophrenia after 6 weeks of clozapine.

  2001cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

  2000cited by this paper
• Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

  2000cited by this paper
• Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.

  1999cited by this paper
• Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

  1999cited by this paper
• The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

  1999cited by this paper
• Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

  1999cited by this paper
• Meta-analysis of symptom factors in schizophrenia.

  1998cited by this paper
• Reversible memory disturbance and intelligence impairment induced by long-term anticholinergic therapy.

  1998cited by this paper
• Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

  1997cited by this paper
• Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study.

  1997cited by this paper
• The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

  1992cited by this paper
• Neuropsychological functioning of first-episode schizophreniform patients.

  1992cited by this paper

• Cognitive Inflexibility Predicts Negative Symptoms Severity in Patients with First-Episode Psychosis: A 1-Year Follow-Up Study

  2024cites this paper
• Prefrontal cortex dysfunction during verbal fluency task after atypicalantipsychotic treatment in schizophrenia: A near-infrared spectroscopy imaging study.

  2018cites this paper
• Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.

  2018cites this paper
• Cognitive impairment in first‐episode drug‐naïve patients with schizophrenia: Relationships with serum concentrations of brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor

  2017cites this paper
• Efectos de la terapia asistida con animales en dominios cognitivos en pacientes con esquizofrenia

  2016cites this paper
• Motivational Deficits in Schizophrenia

  2016cites this paper
• Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: a prospective three-year follow-up study.

  2014cites this paper
• Chapter Three – Neurofeedback and Psychopharmacology: Designing Effective Treatment Based on Cognitive and EEG Effects of Medications

  2014cites this paper
• Neurofeedback and Psychopharmacology

  2014cites this paper
• [First-episode psychosis, cognitive difficulties and remediation].

  2013cites this paper
• Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.

  2013cites this paper
• Can genetics inform the management of cognitive deficits in schizophrenia?

  2012cites this paper
• Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.

  2011cites this paper
• Level of function at discharge as a predictor of readmission among inpatients with schizophrenia.

  2011cites this paper
• A digit symbol coding task as a screening instrument for cognitive impairment in first-episode psychosis.

  2011cites this paper
• Estudio del flujo sanguíneo regional cerebral con (99M)Tc-ECD SPECT durante una tarea de activación frontal antes y después del tratamiento con risperidona en pacientes con esquizofrenia no tratados previamente con neurolépticos

  2011cites this paper
• Impairments in executive functioning in patients with remitted and non-remitted schizophrenia.

  2011cites this paper
• First-episode schizophrenia patients neuropsychologically within the normal limits: evidence of deterioration in speed of processing.

  2010cites this paper